Literature DB >> 16029917

The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model.

Jinbo Fang1, Guiyun Wang, Qiong Yang, Jinna Song, Ye Wang, Li Wang.   

Abstract

The tumor specific antigen epitope melanoma antigen A1(161--169) (MAGE-A1(161--169)) was displayed on the major protein (p VIII) of the filamentous bacteriophage (fd). The immune responses of the phage display particles expressing MAGE-A1(161--169) in mice were studied. Using phage display particles as vaccine was effective in affording protection from tumor growth, inducing growth control of established tumors and prolonging survival of tumor-bearing mice. The hybrid phage particles elicited MAGE-A1(161--169) specific CTL responses, NK activity and DTH. Our results showed that the phage display particles might be a new vaccine candidate for tumor-associated antigen epitope in cancer immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029917     DOI: 10.1016/j.vaccine.2005.05.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  Phage display--a powerful technique for immunotherapy: 2. Vaccine delivery.

Authors:  Justyna Bazan; Ireneusz Całkosiński; Andrzej Gamian
Journal:  Hum Vaccin Immunother       Date:  2012-08-21       Impact factor: 3.452

2.  Lambda phage nanoparticles displaying HER2-derived E75 peptide induce effective E75-CD8+ T response.

Authors:  Atefeh Arab; Jessica Nicastro; Roderick Slavcev; Atefeh Razazan; Nastaran Barati; Amin Reza Nikpoor; Amir Abbas Momtazi Brojeni; Fatemeh Mosaffa; Ali Badiee; Mahmoud Reza Jaafari; Javad Behravan
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 3.  Phage Therapy in the Era of Synthetic Biology.

Authors:  E Magda Barbu; Kyle C Cady; Bolyn Hubby
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

Review 4.  Therapeutic and prophylactic applications of bacteriophage components in modern medicine.

Authors:  Sankar Adhya; Carl R Merril; Biswajit Biswas
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

5.  Triggering DTH and CTL activity by fd filamentous bacteriophages: role of CD4+ T cells in memory responses.

Authors:  Giovanna Del Pozzo; Dina Mascolo; Rossella Sartorius; Alessandra Citro; Pasquale Barba; Luciana D'Apice; Piergiuseppe De Berardinis
Journal:  J Biomed Biotechnol       Date:  2010-04-29

Review 6.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 7.  Phages in vaccine design and immunity; mechanisms and mysteries.

Authors:  Christiaan R de Vries; Qingquan Chen; Sally Demirdjian; Gernot Kaber; Arya Khosravi; Dan Liu; Jonas D Van Belleghem; Paul L Bollyky
Journal:  Curr Opin Biotechnol       Date:  2020-12-11       Impact factor: 9.740

8.  Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.

Authors:  Hamidreza Hashemi; Somayeh Pouyanfard; Mojgan Bandehpour; Zahra Noroozbabaei; Bahram Kazemi; Xavier Saelens; Talat Mokhtari-Azad
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

9.  Induction of protective anti-CTL epitope responses against HER-2-positive breast cancer based on multivalent T7 phage nanoparticles.

Authors:  Somayeh Pouyanfard; Taravat Bamdad; Hamidreza Hashemi; Mojgan Bandehpour; Bahram Kazemi
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

Review 10.  Filamentous bacteriophage fd as an antigen delivery system in vaccination.

Authors:  Antonella Prisco; Piergiuseppe De Berardinis
Journal:  Int J Mol Sci       Date:  2012-04-24       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.